Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
04/2006
04/12/2006EP1643989A1 Cis-imidazolines as mdm2 inhibitors
04/12/2006EP1643960A2 Arylsulfonamide derivatives
04/12/2006EP1311499B1 Bicyclic compounds as h3 receptor ligands
04/12/2006EP1311471B1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines
04/12/2006EP1005356B1 Novel antibacterial agents
04/12/2006EP0903337B1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
04/12/2006CN1759105A Insecticidal phthalamide derivatives
04/12/2006CN1757638A Imidazole type functional ion liquid having N-substituted amide structure fragment, and its prepn. method
04/12/2006CN1250735C Method for production of non-proteinogen L-amino acid by fermentation
04/11/2006US7026358 Oral general anesthetics and metabolitically resistant anticonvulsants
04/11/2006US7026357 Diphenylurea compounds
04/11/2006US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases
04/11/2006US7026345 Resolution of 3-amino alkylnitriles
04/11/2006US7026339 Inhibitors of HCV NS5B polymerase
04/11/2006CA2274530C Process for producing 5-arylthio imidazole derivatives
04/06/2006WO2006036512A2 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
04/06/2006WO2006036497A2 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
04/06/2006WO2006036480A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
04/06/2006WO2006036404A1 4-(substituted cycloalkylmethyl) imidazole-2-thones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cyloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
04/06/2006WO2006035960A2 Process for production of 2-chloro-4-nitroimidazole
04/06/2006US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors
04/06/2006US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
04/06/2006DE60202958T2 Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten Stable polymorph of flibanserin, industrial process for its production and its use for the preparation of medicaments
04/06/2006DE102005008406A1 Conductive liquid, useful for inclination- and acceleration sensors and in inclination switches, comprises ionic liquid
04/06/2006CA2582071A1 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
04/06/2006CA2581823A1 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
04/06/2006CA2581579A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
04/06/2006CA2580139A1 Process for production of 2-chloro-4-nitroimidazole
04/05/2006EP1641765A1 Aryl-heteroaromatic products, compositions containing same and use thereof
04/05/2006EP1641764A1 5-membered heterocycle-based p38 kinase inhibitors
04/05/2006EP1641452A1 Heterocyclic compounds useful to treat hcv
04/05/2006EP1377557B1 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor
04/05/2006CN1754880A Process for preparing 2-iminopyrrolidine derivatives
04/05/2006CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
04/05/2006CN1249053C Nitrate salt of anti-ulcer medicine
04/05/2006CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
04/04/2006US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy
04/04/2006US7022845 Monomethylation of nitrogeneous heterocycles
04/04/2006US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes
04/04/2006US7022704 5,6,7, 8-tetrahydro-imidazo-(1,2a)-pyrazine derivative; useful for treating restenosis and tumor
04/04/2006CA2294624C Cationic monobenzene nitrophenylenediamines, their use in dying keratin fibres, dyeing compositions containing them and dyeing processes
04/04/2006CA2291075C Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions
04/04/2006CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
03/2006
03/30/2006WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
03/30/2006WO2005047899A3 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation
03/30/2006WO2004053071A3 Method for discovering neurogenic agents
03/30/2006US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation
03/30/2006US20060069146 Cardiovascular disordders; antiarrhythmia agents; neurodegenerative diseases; antidepressants; bipolar disorders; irritable bowel disorders
03/30/2006US20060069142 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
03/30/2006US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
03/30/2006CA2580238A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
03/29/2006EP1640366A1 Heterocyclic methyl sulfone derivative
03/29/2006EP1639029A2 Biodegradable poly(beta-amino esters) and uses thereof
03/29/2006EP1638944A1 Tachykinin receptor antagonists
03/29/2006EP1638943A2 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
03/29/2006EP1638942A1 Cis-2,4,5-triaryl-imidazolines
03/29/2006EP1501806B1 Preparations for the topical application of anti-androgenically active substances
03/29/2006EP1303270B1 Method for treating cryptorchidism
03/29/2006EP1227086B1 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof
03/29/2006EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor
03/29/2006CN1753882A Ethynyl derivatives serving as factor XA inhibitors
03/29/2006CN1752077A Preparation method of new 2-n-propyl imidazole-4,5-dicarboxylic acid
03/29/2006CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
03/28/2006US7019030 Immunotherapeutic agents
03/28/2006US7019021 such as 2-(6-bromo-3-dimethylamino-2-methylphenylimino)imidazolidine; stress
03/28/2006US7019019 Matriptase inhibitors and methods of use
03/28/2006US7019003 Bactericides
03/28/2006US7018599 Fullerene derivatives
03/28/2006CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/28/2006CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
03/23/2006WO2006029850A1 Hydrazone derivatives and their use as beta secretase inhibitors
03/23/2006WO2006029812A1 Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof
03/23/2006US20060063945 Process for the preparation of ionic liquids with alkyl sulfate and functionalized alkyl sulfate anions
03/23/2006US20060063843 Compounds for the treatment of inflammatory disorders
03/23/2006US20060063820 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
03/23/2006US20060063819 Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
03/23/2006US20060063818 Hydantoin derivatives and deren verwendung als tace inhibitoren
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006DE19547099B4 Verfahren zur Herstellung von (Meth)acrylsäureestern Acrylic acid esters, process for the preparation of (meth)
03/23/2006DE112004000967T5 Elektrolytlösung für ein elektronisches Element, Verfahren zur Suche nach derselben, Verfahren zu ihrer Herstellung und elektronisches Element Electrolytic solution for an electronic element method to search for the same, processes for their preparation and electronic element
03/23/2006CA2580033A1 Imidazole compound
03/23/2006CA2579799A1 Benzoyl-substituted serine amides
03/23/2006CA2579514A1 Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms)
03/23/2006CA2579472A1 Hydrazone derivatives and their use as beta secretase inhibitors
03/22/2006EP1637566A1 Cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit
03/22/2006EP1636189A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
03/22/2006EP1636188A1 Para-substituted phenyl carbamates as inhibitors of hormone sensitive lipase
03/22/2006EP1636173A2 Ionic liquids containing guanidinium cations
03/22/2006EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases
03/22/2006EP1315697B1 Herbicidal benzoyl cyclohexane dione
03/22/2006EP1221847A4 Methods of enhancing chemotherapy
03/22/2006CN1751053A Salts comprising cyanoborate anions
03/22/2006CN1749249A Chiral ionic liquid and its preparing method
03/22/2006CN1245938C Novel dyeing composition for dyeing-keratinous fibers comprising particular dicationic diazo dye
03/21/2006US7015333 Process for preparation of imidazolyl compounds
03/21/2006US7015331 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
03/21/2006CA2238986C Compounds with isocyanate groups and masked groups reactive in relation to isocyanates
03/21/2006CA2186285C Carbonyl containing compounds and their derivatives as multi-functional fuel and lube additives
03/21/2006CA2072416C Cyclopropenone derivatives
03/16/2006WO2006028226A1 Novel imidazolidine derivative and use thereof